Terms of reference:
The purpose of this website is to document global good practice care in Atopic Dermatitis. This website was commissioned and funded by Sanofi Inc, Genzyme Europe B.V., and Regeneron Pharmaceuticals Inc. (collectively referred to as “Sanofi Genzyme & Regeneron”). KPMG LLP (“KPMG”) has had sole responsibility for its contents and editorial oversight. Sanofi Genzyme & Regeneron had no role in collection, management, analysis or interpretation of data, or preparation of the final report.
This website is owned by KPMG and is subject to KPMG copyright. The website is based on the Improving Quality of Care in Atopic Dermatitis report.
Roles and responsibilities of contributors:
- This study was solely conducted by KPMG, including the collection, study, management, analysis and interpretation of data, and the preparation of the report and website.
- Steering committee: The committee consisted of four experts from across the globe who provided guidance and advice throughout the development of the report.
- Other contributing specialists: All experts were given an opportunity to review their centre-specific report and this report. Guidance and feedback from all experts were incorporated into this report.
- This website and report was commissioned and funded by Sanofi Genzyme & Regeneron. Sanofi Genzyme & Regeneron had no role in the collection, management, analysis or interpretation of data, or preparation of the final report.
Disclaimers:
KPMG has collected information from the interviewees but KPMG has not independently verified the information they have provided. The information used in compiling this website and report may have been incomplete or inaccurate. KPMG accepts no liability for any inaccuracies or omissions.
The views expressed in this website and report shall not amount to any form of guarantee that KPMG has determined or predicted events, whether present or future.
The information contained in this report is based on prevailing conditions and KPMG’s view (based on information collected from the interviewees) as at 11 March 2020. KPMG has not undertaken to, nor shall KPMG be under any obligation to, update this report or revise the information contained in this report for events or circumstances arising after 11 March 2020.
The website constitutes research and is not suitable to be relied upon in terms of making decisions. Any third party that obtains this website uses it entirely at its own risk.
Any such person or organisation who chooses to rely on this website will do so at its own risk. To the fullest extent permitted by law, KPMG will accept no responsibility or liability in respect of this report to any other person.
©
KPMG LLP a UK limited liability partnership and a member firm of the KPMG global organisation of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.
For more detail about the structure of the KPMG global organisation please visit https://home.kpmg/governance
KPMG International Cooperative (“KPMG International”) is a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.